Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesQuestions about Chemokine and Chemokine Receptor Antagonism in Renal Inflammation
Nephron: Experimental Nephrology, 11/03/09
Anders HJ et al. – Chemokines remain attractive therapeutic targets for modulating inflammatory diseases in all areas of medicine including acute and chronic kidney disease. Industry has launched huge programs for the development of chemokine antagonists, and clinical trials with chemokine and chemokine receptor antagonists are ongoing.
Related Articles
Acute Decline in Renal Function, Inflammation, and Cardiovascular Risk after an Acute Coronary Syndrome
Clinical Journal of the American Society of Nephrology, 11/13/09
Relevance Score: 69%
Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure
Nephrology Dialysis Transplantation, 11/25/09
Relevance Score: 68%
Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09
Relevance Score: 68%
Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of beta2-adrenoceptor
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 67%
SLCO4C1 Transporter Eliminates Uremic Toxins and Attenuates Hypertension and Renal Inflammation
Journal of the American Society of Nephrology, 11/23/09
Relevance Score: 66%
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Biological variation of cystatin C and creatinine
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection
The Journal of Urology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor